Global PCR Reagent and Kit Market Research Report 2022

Due to the COVID-19 pandemic, the global PCR Reagent and Kit market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe PCR Reagent and Kit market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe PCR Reagent and Kit landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Built-in Hot Start accounting for % of the PCR Reagent and Kit global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Gene Expression Analysis segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of PCR Reagent and Kit include Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Promega Corp., Boster Bio, Analytik Jena US LLC, Applied Biological Materials, Inc., GenScript USA Inc., ABclonal Technology and Best Chance Products, LLC, etc. In terms of revenue, the global 3 largest players have a % market share of PCR Reagent and Kit in 2021.
This report focuses on PCR Reagent and Kit volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall PCR Reagent and Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global PCR Reagent and Kit Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Built-in Hot Start
No built-in Hot Start
Segment by Application
Gene Expression Analysis
Genetic Variation Analysis
Mutation Detection
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Thermo Fisher Scientific
Bio-Rad Laboratories, Inc.
Promega Corp.
Boster Bio
Analytik Jena US LLC
Applied Biological Materials, Inc.
GenScript USA Inc.
ABclonal Technology
Best Chance Products, LLC
Tonbo Biosciences
Ampliqon
Bioneer Corporation
Genomic Expression